Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zogenix Inc.

www.zogenix.com

Latest From Zogenix Inc.

Deal Watch: BMS To Tap Early-Stage Breakthroughs In Partnership With BioMotiv

Bristol-Myers Squibb will partner with the biotech accelerator to fund and launch biotechs, with the pharma getting an option to buy. Novartis signs another agreement with IFM months after buying its IFM Tre affiliate.

Deals Business Strategies

Zogenix To Pay $250m Upfront To Buy Modis For Ultra-Orphan Drug

The takeover will diversify Zogenix’s pipeline through the addition of MT1621, a drug that improved the probability of survival in patients with an inherited mitochondrial DNA depletion disorder.

Companies Deals

Resubmission After Withdrawal: US FDA’s Mavenclad Approval Acknowledges Long Regulatory History

EMD Serono’s multiple sclerosis drug joins small cadre of products that survived a refuse to file letter and NDA withdrawal; chart details recent RTFs and application withdrawals.

Drug Approval Standards Drug Review

Keeping Track: NME Approvals For Evenity And Balversa; Non-NME Approvals For Dovato And Keytruda; But An RTF For Fintepla

The latest drug development news and highlights from our US FDA Performance Tracker. 
Drug Review Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • SJ2 Therapeutics Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Zogenix Inc.
  • Senior Management
  • Stephen J Farr, PhD, Pres. & CEO
    Michael P Smith, EVP, CFO, Treasurer & Secretary
    Bradley S Galer, MD, EVP, CMO
    Gail M Farfel, PhD, EVP, Chief Dev. Officer
    Ashish Sagrolikar, EVP, Chief Commercial Officer
  • Contact Info
  • Zogenix Inc.
    Phone: (858) 259-1165
    5858 Horton St.
    Ste. 455
    Emeryville, CA 94608
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register